Not Yet RecruitingNCT06957704

Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents

This not yet recruiting study focuses on depression and currently lists sites or participation links in Global.

DepressionOtherFrom 12 Years to 19 Years

In plain English

Key information made simple

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care. For people living with Depression, being understood earlier and more clearly can shape the whole care journey. If the findings are useful, they could help shape larger studies and better designed support in the future. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record does not clearly spell out the visit format, but it appears to be coordinated directly by the research team. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis and having a stable enough treatment background for the study, while common reasons not to take part include active substance or alcohol problems that could affect the results and pregnancy or breastfeeding. This is a later-stage study, which usually means a larger group and a closer look at how well the approach holds up.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT06957704. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com